We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
+2.13%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$1.22B
AUM Growth
+$77.6M
Cap. Flow
+$59.9M
Cap. Flow %
4.93%
Top 10 Hldgs %
46.33%
Holding
332
New
35
Increased
189
Reduced
69
Closed
18

Sector Composition

Rank Sector Weight
1 Miscellaneous 82.41%
2 Technology 7.75%
3 Healthcare 2.78%
4 Financials 1.79%
5 Communication Services 1.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IJH icon
51
iShares Core S&P Mid-Cap ETF
IJH
$124B
$3.81M 0.31%
+65,165
New +$3.83M
TOTL icon
52
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.99B
$3.78M 0.31%
95,058
+2,438
+3% +$96.2K
VDE icon
53
Vanguard Energy ETF
VDE
$10.7B
$3.65M 0.3%
28,634
-1,339
-4% -$174K
LLY icon
54
Eli Lilly
LLY
$1.05T
$3.57M 0.29%
3,943
+536
+16% +$429K
JMST icon
55
JPMorgan Ultra-Short Municipal Income ETF
JMST
$7.26B
$3.54M 0.29%
69,721
-8,176
-10% -$414K
IVW icon
56
iShares S&P 500 Growth ETF
IVW
$76.8B
$3.54M 0.29%
+38,227
New +$3.3M
NVO
57
Novo Nordisk
NVO
$202B
$3.53M 0.29%
24,697
+1,155
+5% +$153K
TSLA icon
58
Tesla
TSLA
$1.38T
$3.48M 0.29%
17,567
+1,971
+13% +$344K
GEM icon
59
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.75B
$3.44M 0.28%
105,196
-9,372
-8% -$300K
VXUS icon
60
Vanguard Total International Stock ETF
VXUS
$163B
$3.19M 0.26%
52,983
+378
+0.7% +$22.8K
OMFL icon
61
Invesco Russell 1000 Dynamic Multifactor ETF
OMFL
$4.83B
$3.07M 0.25%
58,415
-19
-0% -$1.01K
ORCL icon
62
Oracle
ORCL
$435B
$3M 0.25%
21,280
+253
+1% +$31.4K
BRK.B icon
63
Berkshire Hathaway Class B
BRK.B
$1.08T
$2.84M 0.23%
6,981
+3,001
+75% +$1.23M
META icon
64
Meta Platforms (Facebook)
META
$1.47T
$2.44M 0.2%
4,834
+398
+9% +$193K
VRTX icon
65
Vertex Pharmaceuticals
VRTX
$137B
$2.08M 0.17%
4,440
+108
+2% +$46.9K
AVES icon
66
Avantis Emerging Markets Value ETF
AVES
$1.54B
$2.02M 0.17%
41,485
+926
+2% +$45K
XLU icon
67
State Street Utilities Select Sector SPDR ETF
XLU
$21.9B
$1.97M 0.16%
57,794
-1,808
-3% -$62.1K
NFLX icon
68
Netflix
NFLX
$340B
$1.94M 0.16%
28,760
+620
+2% +$38.7K
AVGO icon
69
Broadcom
AVGO
$1.75T
$1.89M 0.16%
11,780
+1,510
+15% +$212K
COST icon
70
Costco
COST
$419B
$1.88M 0.16%
2,217
+223
+11% +$174K
JPM icon
71
JPMorgan Chase
JPM
$951B
$1.88M 0.15%
9,280
+1,362
+17% +$266K
VO icon
72
Vanguard Morningstar Mid-Cap ETF
VO
$109B
$1.87M 0.15%
30,952
+2,144
+7% +$130K
VOO icon
73
Vanguard S&P 500 ETF
VOO
$1.03T
$1.87M 0.15%
3,734
+65
+2% +$31.3K
SCHA icon
74
Schwab U.S Small- Cap ETF
SCHA
$22.7B
$1.82M 0.15%
76,630
-88
-0.1% -$2.09K
AVIV icon
75
Avantis International Large Cap Value ETF
AVIV
$2.11B
$1.8M 0.15%
34,288
-2,674
-7% -$144K

Similar funds

Callan Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Callan Capital held 332 positions worth $1.22B, up 6.8% from $1.14B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Callan Capital deployed $59.9M of net new capital in Q2 2024, opening 35 new positions and adding to 189 existing holdings. Its largest new stake was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.

By sector, the portfolio is most concentrated in Miscellaneous at 82% of assets, down from 86% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Vanguard Tax-Exempt Bond Index Fund, an estimated $1.96M trimmed.

  • Callan Capital's largest Q2 2024 buy was iShares Core S&P Mid-Cap ETF: 65,165 shares worth $3.81M.
  • Callan Capital added most to NVIDIA in Q2 2024, an estimated $18.4M increase.
  • Callan Capital's biggest Q2 2024 reduction was Vanguard Tax-Exempt Bond Index Fund, cutting an estimated $1.96M.
  • Callan Capital fully exited Takeda Pharmaceutical in Q2 2024, selling an estimated $354K.
  • Callan Capital's ten largest holdings make up 46% of its $1.22B portfolio in Q2 2024.
  • Callan Capital opened 35 new positions and closed 18 in Q2 2024.
  • Callan Capital's portfolio value rose 6.8% quarter-over-quarter to $1.22B.

Based on Callan Capital's 13F filing for Q2 2024, filed 12 Aug 2024.